Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
Cancer Medicine|November 21, 2023
The mutational pattern of homologous recombination repair genes in urothelial carcinoma and its correlation with immunotherapeutic responseJunru Chen, Yanfeng Tang, Huanhuan Liu, et al.
Molecular Cancer|August 11, 2020
ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1Yunhao Chen, Yanchun Zhao, Junru Chen, et al.
Japanese Journal of Clinical Oncology|July 29, 2020
The influence of dynamic changes in lipid metabolism on survival outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitorsXingming Zhang, Haoran Zhang, Jindong Dai, et al.
Cancer Treatment Reviews|June 21, 2024
The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysisYaowen Zhang, Junru Chen, Haoyang Liu, et al.
Cancer Letters|December 19, 2020
ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathwayJunru Chen, Chaofeng Ding, Yunhao Chen, et al.
Cancer Management and Research|September 13, 2021
Efficacy and Safety of Individualized Schedule of Sunitinib by Drug Monitoring in Patients with Metastatic Renal Cell CarcinomaXudong Zhu, Xingming Zhang, Guangxi Sun, et al.
Molecular Cancer|August 24, 2019
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1Yunhao Chen, Chuanhui Peng, Junru Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 4, 2023
KLF14 regulates the growth of hepatocellular carcinoma cells via its modulation of iron homeostasis through the repression of iron-responsive element-binding protein 2Hui Zhou, Junru Chen, Mingjie Fan, et al.
The Prostate|March 4, 2025
The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone AcetateYifu Shi, Xinyuan Wei, Fengnian Zhao, et al.
Ebiomedicine|May 22, 2019
Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5Xiaoyu Weng, Jingbang Wu, Zhen Lv, et al.
Pageof 20